Revisiting Screening in Women With a Family History of Breast Cancer.
Kristen CoffeyVictoria Lee MangoPublished in: Journal of breast imaging (2023)
Women with a family history (FH) of breast cancer and without known genetic susceptibility represent a unique population whose lifetime probability of developing breast cancer varies widely depending on familial factors, breast density, and the risk assessment tool used. Recently updated guidelines from the American College of Radiology recommend supplemental annual screening with contrast-enhanced MRI or contrast-enhanced mammography for women with an FH who are high risk (≥20% lifetime risk) or have dense breasts. To date, most screening studies addressing outcomes in women with FH have largely included those also with confirmed or suspected gene mutations, in whom the lifetime risk is highest, with limited data for women at average to intermediate risk who are not known to be genetically susceptible and may not benefit as much from the same screening approaches. Further research focusing specifically on women with FH as the only breast cancer risk factor is warranted to refine risk assessment and optimize a multimodality personalized screening approach.
Keyphrases
- contrast enhanced
- magnetic resonance imaging
- diffusion weighted
- computed tomography
- magnetic resonance
- risk assessment
- diffusion weighted imaging
- polycystic ovary syndrome
- machine learning
- electronic health record
- metabolic syndrome
- copy number
- artificial intelligence
- pulmonary embolism
- pregnant women
- skeletal muscle
- dual energy
- genome wide
- childhood cancer
- data analysis
- weight loss